Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 507-510, February 1, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakagawa, K.
Right arrow Articles by Edwards, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakagawa, K.
Right arrow Articles by Edwards, M. J.

Mechanisms of Interleukin-2-induced Hepatic Toxicity1

Koji Nakagawa, Frederick N. Miller, David E. Sims, Alex B. Lentsch, Masaru Miyazaki and Michael J. Edwards2

Departments of Surgery [K. N., M. J. E.] and Physiology and Biophysics [F. N. M., A. B. L.], University of Louisville, Louisville, Kentucky 40292; Department of Anatomy and Physiology, University of Prince Edward Island, Charlottestown, PE C1A 4P3 Canada [D. E. S.]; and The First Department of Surgery, Chiba University, Chiba, Japan [M. M.]

Interleukin 2 (IL-2) mediates the regression of metastatic cancer, but its clinical use is limited by associated toxicities including hepatic dysfunction. To determine the mechanism for IL-2-induced hepatic dysfunction, we hypothesized that IL-2 activation of Kupffer cells cause leukocyte-endothelial adhesion and decreases hepatic sinusoidal blood flow. C57BL/6 mice were given injections of latex particles and prepared for intravital hepatic microscopy 2 h after i.p. IL-2 administration. Liver tissue was also prepared to quantitate hepatic tumor necrosis factor (TNF) mRNA and processed for light and electron microscopy. Phagocytosing Kupffer cells and leukocytes adherent to the endothelium were counted, and surface sinusoidal blood flow was quantitated. Kupffer cell activity was quantitated as the ratio of phagocytosing Kupffer cells to sinusoidal blood flow. IL-2 significantly increased Kupffer cell activity (0.56 ± 0.05 for controls versus 0.84 ± 0.05 for IL-2), significantly caused leukocyte-endothelial adhesion (26.7 ± 7.9 for controls versus 87.0 ± 27.6 for IL-2, WBC/mm2 endothelial surface), and significantly decreased the number of sinusoids containing blood flow per microscopic field (6.66 ± 0.15 for controls versus 5.79 ± 0.13 for IL-2) without causing changes in systemic hemodynamic parameters. In IL-2-treated livers, light and electron microscopy showed the constriction of sinusoids associated with swollen or ruptured mitochondria, which was consistent with hypoxic deterioration near central venules. Adherent platelets, neutrophils, and lymphocytes within sinusoids and central venules were also observed. PCR revealed that IL-2 significantly induced TNF mRNA expression in the liver. These data suggest that IL-2 activate Kupffer cells in association with the release of monokines including TNF, which causes activation of circulating leukocytes as well as hepatic sinusoidal endothelial cells. The resultant leukocyte and platelet adhesion to the endothelium may then physically impede the sinusoidal microcirculation, resulting in microscopic areas of hepatic ischemia and explaining the mechanism of IL-2-induced hepatic dysfunction.

1 This work was supported by NIH Grant CA-57527.

2 To whom requests for reprints should be addressed, at Department of Surgery, J. Graham Brown Cancer Center, University of Louisville, 529 South Jackson Street, Louisville, KY 40292. Phone: (502) 852-7827; Fax: (502) 852-8031; E-mail: mjedwa01@ulkyvm.louisville.edu.

Received 11/15/95. Accepted 12/14/95.




This article has been cited by other articles:


Home page
The OncologistHome page
P. D. King and M. C. Perry
Hepatotoxicity of Chemotherapy
Oncologist, April 1, 2001; 6(2): 162 - 176.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. M. Kemeny, G. I. Botchkina, M. Ochani, M. Bianchi, C. Urmacher, and K. J. Tracey
The tetravalent guanylhydrazone CNI-1493 blocks the toxic effects of interleukin-2 without diminishing antitumor efficacy
PNAS, April 14, 1998; 95(8): 4561 - 4566.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
D Rowbotham, J Wendon, and R Williams
Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases
Gut, April 1, 1998; 42(4): 576 - 580.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.